9 results
8-K
ODYY
Odyssey Health, Inc.
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
no longer be true as of a given date; and may apply standards of materiality in a way that is different from what may be viewed as material by shareholders
8-K
EX-2.1
ODYY
Odyssey Health, Inc.
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
are qualified by materiality will be true and correct in all respects and (ii) which are not qualified by materiality will be true and correct in all … . The representations and warranties of the Additional Parties and the Company set forth in Article 4 (i) which are qualified by materiality will be true
S-3
EX-5.1
fk3pgl2i794
17 Mar 21
Shelf registration
4:30pm
8-K
EX-10.5
c6vkx1x
8 Jan 21
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-10.1
ipv9cxxctj
17 Aug 20
Entry into a Material Definitive Agreement
7:00am
- Prev
- 1
- Next